Telmisartan Nanosuspension for Inhaled Therapy of COVID-19 Lung Disease and Other Respiratory Infections

Vaccine hesitancy and the occurrence of elusive variants necessitate further treatment options for coronavirus disease 2019 (COVID-19). Accumulated evidence indicates that clinically used hypertensive drugs, angiotensin receptor blockers (ARBs), may benefit patients by mitigating disease severity an...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Molecular pharmaceutics 2023-01, Vol.20 (1), p.750-757
Hauptverfasser:	Chen, Daiqin, Yun, Xin, Lee, Daiheon, DiCostanzo, Joseph R., Donini, Oreola, Shikuma, Cecilia M., Thompson, Karen, Lehrer, Axel T., Shimoda, Larissa, Suk, Jung Soo
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin Receptor Antagonists - pharmacology Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - pharmacology Angiotensin-Converting Enzyme Inhibitors - therapeutic use Animals COVID-19 Renin-Angiotensin System - physiology Respiratory Tract Infections - drug therapy SARS-CoV-2 Telmisartan
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!